AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 151 min read$IBEX

Inson Paul Joseph sold $91K of IBEX

Inson Paul Joseph (Chief People Officer) sold 2,274 shares of IBEX Ltd (IBEX) at $40.00 on 2026-09-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Inson Paul Joseph
Published Sep 15, 2026, 9:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$IBEX
Neutral
high confidence
Mentioned
$IBEX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBEXNeutralLow
01

Why it matters

The insider sale is routine and unlikely to affect price; serves as a compliance update.

02

Market read

Low relevance; typical insider sale with minimal market impact.

03

What to watch

Potential upcoming compensation changes for executives.

Relevance 2/10Novelty 4/10Timing: filed Sep 15 2026

Background

Form 4 filings disclose insider transactions; traders monitor large sales for red flags.

Company-level read

Ticker impact

$IBEXNeutralHigh confidence
Context

Chief People Officer sold 2,274 shares for $90,960 via a 10b5‑1 plan, reducing his stake to 29,724 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale size is small relative to typical float and disclosed via a primary Form 4 filing.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

The sale could be seen as a signal of insider concern, but size is too small to matter.

Key entities

  • Person
    Inson Paul Joseph

    Chief People Officer of IBEX Ltd.

  • Company
    IBEX Ltd

    Issuer of the shares sold.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IBEX insider trading history →

Related articles

SEP 13
$IBEXHighAI 8/10

IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine

IBEX (IBEX) reported record full-year revenue of $644.1M, up 15.4%, and Q4 revenue of $164.3M, up 11.6%. Growth was driven by HealthTech, Technology, and Travel & Logistics. AI partnerships with Philippine Airlines and BJ's Wholesale showed strong results. Q4 net income fell to $8.7M, and EPS dropped to $0.59 due to training and operational costs.

yahoo.com2 min
SEP 11
$IBEXMedAI 8/10

IBEX (IBEX) Q4 2026 Earnings Call Transcript

IBEX (IBEX) reported fiscal year 2026 revenue of $644.1 million, up 15.4%, with Q4 revenue at $164.3 million, up 11.6%. Adjusted EBITDA reached $82.4 million, a 14.5% increase. HealthTech revenue grew 38.5% to $114 million. Guidance for 2027 projects revenue of $700M-$715M and adjusted EBITDA of $90M-$94M. The company highlighted growth in AI-powered services and strategic partnerships.

aol.com2 min
SEP 10
$IBEXHigh

IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two

SEC EDGAR 8-K3 min